Table 4 The predictive value of PCDH8 methylation for the progression-free survival in non muscle invasive bladder cancer (n = 233)

PCDH8 methylation (M vs. U)

4.893

1.872-9.433

<0.0001

2.523

1.654-7.431

0.0036

Age (>65 vs. ≦65)

0.896

0.873-5.215

0.8614

Sex (Male vs. Female)

1.213

0.855-5.217

0.5461

Number (Multiple vs. Single)

1.322

0.729-8.537

0.4668

Size (>3 cm vs. ≤3 cm)

1.227

0.579-11.460

0.4962

Grade (G₃ vs. G₁ / G₂)

3.679

1.463-7.754

0.0017

1.874

1.237-6.873

0.0233

Stage (T₁ vs. T_a)

1.625

0.893-6.792

0.0614